References
- Messing, EM, Catalona, W. Bladder cancer. In: PC Walsh, Retik, AB, Vaughan, ED, Jr, Wein, AJ. Campbell's urology. Philadelphia, PA: WB Saunders; 1997. p 2360–73.
- Shelley, MD, Barber, J, Wilt, T, Mason, MD. Surgery versus radiotherapy for muscle invasive bladder cancer. Cochrane Database Syst Rev 2001; 4
- Mikulowski P, Hellsten S. T1G1 urinary bladder carcinoma: fact or fiction?. Scand J Urol Nephrol 2005; 39: 135–7
- Gårdmark, T, Bladström, A, Hellsten, S, Malmström P-U, Members of the Swedish National Bladder Cancer Registry. Analysis of clinical characteristics, management and survival of patients with Ta, T1 bladder tumours in Sweden between 1997 and 2001. Scand J Urol Nephrol 2006;40:276–82.
- Holmäng S, Hedelin H, Anderström C, Johansson SL. Long-term follow-up of patients with muscle invasive (stages T2, T3 and T4) bladder carcinoma in a geographical region. J Urol 1997; 158: 389–92
- Snyder C, Harlem L, Knopf K, Potosky A, Kaplan R. Patterns of care for the treatment of bladder cancer. J Urol 2003; 169: 1697–701
- Prout GR, Welsey MN, Yannick R, Ries LA, Havlik RJ, Edwards BK. Age and co-morbidity impact surgical therapy in older bladder cancer patients: a population-based study. Cancer 2005; 104: 1638–47
- Puente D, Malats N, Cecchini L, Tardón A, García-Closas R, Serra C, et al. Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol 2003; 43: 53–62
- Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 2003; 170: 1765–71
- P Hermanek, Sobin, LH. TNM classification of malignant tumours4th ed. Berlin: Springer; 1987.
- LH Sobin, Wittekind, Ch. TNM classification of malignant tumours5th ed. New York: Wiley-Liss; 1997.
- Hollenbeck BK. Quality of care: partial cystectomy for bladder cancer – a case of inappropriate use?. J Urol 2005; 174: 1050–4
- Schrag D, Mitra N, Xu F, Rabbani F, Bach PB, Herr H, Begg CB. Cystectomy for muscle-invasive bladder cancer: patterns of care and outcomes of care in the Medicare population. Urology 2005; 65: 1118–25
- Malmström PU, Thörn M, Lindblad P, Bergström R, Adami HO. Increasing survival of patients with bladder cancer. A nation wide study 1960–1986. Eur J Cancer 1993; 29A: 1868–72
- Taub DA, Hollenbeck BK, Cooper KL, Dunn RL, Miller DC, Taylor JM, Wei JT. Racial disparities in resource utilisation for cystectomy. Urology 2006; 67: 288–93
- Hollenbeck BK, Miller DC, Taub D, Dunn RL, Underwood W, Montie JE, Wei JT. Aggressive treatment bladder cancer is associated with improved overall survival among patients 80 years or older. Urology 2004; 64: 292–7
- Mungan N, Kiemeney L, van Dick J, van der Poel H, Witjes J. Gender differences in stage distribution of bladder cancer. Urology 2000; 55: 368–71
- Cardenaz-Turanzas M, Cooksley C, Pettaway CA, Sabichi A, Grossman HB, Elting L. Comparative outcomes of bladder cancer. Obstet Gynecol 2006; 108: 169–75
- Fleshner NE, Herr HE, Stewart AK, Murphy GP, Mettlin C, Menck HR. The National Cancer Database report on bladder carcinoma. Cancer 1996; 78: 1505–13